ALIGN: Aligning Medications With What Matters Most (Demonstration)

Completed · Not applicable

Conditions studied: Polypharmacy, Alzheimer's Disease and Related Dementias, Mild Cognitive Impairment

In brief

The goal of this clinical trial is to test the effectiveness of a pharmacist-led, primary care-based de-prescribing intervention for people living with dementia (PLWD) and the person's care partners. The intervention consists of the following strategies: 1) a de-prescribing educational brochure designed to activate the patient and care partner; 2) a single telehealth visit in which an embedded clinical pharmacist discusses the benefits and harms of the patient's medications with the patient and care partner in the context of the person's goals and preferences; and 3) pharmacist-PCP communication in which the pharmacist provides tailored de-prescribing recommendations designed to be useful and actionable for the PCP. The investigators will compare the intervention group with the waitlist control group to see if there is a difference in the primary outcome, the proportion of patients who deprescribe at least one medication by 3 months.

Key facts

Study ID
NCT06335953
Run by
Johns Hopkins University
People needed
474
Starts
2024-05-07
Expected to finish
2025-10-18
Last updated by the study team
2026-08-06

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.